100432-06-2 Usage
General Description
(1-amino-2-propenyl)phosphonic acid, also known as alendronic acid, is a synthetic bisphosphonate medication that is used to treat and prevent osteoporosis in postmenopausal women and to increase bone mass in men with osteoporosis. It works by inhibiting bone resorption, making bones stronger and less likely to break. (1-amino-2-propenyl)phosphonic acid is also used to treat Paget's disease of the bone, hypercalcemia of malignancy, and other conditions that cause the bones to weaken. This medication is typically taken orally on an empty stomach, and it is important to follow the dosing instructions and any dietary restrictions given by a healthcare professional to ensure its effectiveness. Side effects may include gastrointestinal issues, musculoskeletal pain, and skin reactions, and it should not be used in individuals who have difficulty standing or sitting upright for at least 30 minutes.
Check Digit Verification of cas no
The CAS Registry Mumber 100432-06-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,0,4,3 and 2 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 100432-06:
(8*1)+(7*0)+(6*0)+(5*4)+(4*3)+(3*2)+(2*0)+(1*6)=52
52 % 10 = 2
So 100432-06-2 is a valid CAS Registry Number.
InChI:InChI=1/C3H8NO3P/c1-2-3(4)8(5,6)7/h2-3H,1,4H2,(H2,5,6,7)
100432-06-2Relevant articles and documents
(1-Amino-2-propenyl)phosphonic acid, an Inhibitor of Alanine Racemase and D-Alanine:D-Alanine Ligase
Vo-Quang, Yen,Carniato, Denis,Vo-Quang, Liliane,Lacoste, Anne-Marie,Neuzil, Eugene,Goffic, Francois Le
, p. 579 - 581 (2007/10/02)
DL-(1-Amino-2-propenyl)phosphonic acid was synthesized through the sequential oxidation, sulfoxide elimination, and deprotection of diphenyl -3-(phenylthio)propyl>phosphonate.This analogue of vinylglycine is a strong inhibitor
